Blog

  • AI Identifies Post-Surgery Infections From Patient Photos

    AI Identifies Post-Surgery Infections From Patient Photos


    Register for free to listen to this article

    Thank you. Listen to this article using the player above.


    Want to listen to this article for FREE?


    Complete the form below to unlock access to ALL audio articles.

    Researchers at Mayo Clinic have developed an artificial intelligence (AI) system capable of analyzing patient-submitted photographs of postoperative wounds to identify surgical site infections (SSIs).

    The study, published in Annals of Surgery, describes a multi-step pipeline trained on more than 20,000 images collected from over 6,000 patients treated across 9 Mayo Clinic hospitals.

    The AI system is trained to perform three functions: it first determines whether a submitted image contains a surgical incision, then assesses the quality of the image and finally evaluates the incision for signs of infection. 

    Supporting outpatient recovery with automated screening

    With the increasing shift to outpatient surgeries and virtual follow-up care, clinicians are often required to assess postoperative recovery remotely. This approach can delay diagnosis if images are not reviewed promptly. 

    “We were motivated by the increasing need for outpatient monitoring of surgical incisions in a timely manner,” said Cornelius Thiels, D.O., a hepatobiliary and pancreatic surgical oncologist at Mayo Clinic and co-senior author of the study. “This process, currently done by clinicians, is time-consuming and can delay care. Our AI model can help triage these images automatically, improving early detection and streamlining communication between patients and their care teams.”

    The model’s operates using a two-stage model. First, it begins with incision detection. If an incision is confirmed, the wound features are then assessed to evaluate whether there are any signs of infection.

    The model has achieved 94% accuracy in identifying incision presence and achieved an area under the curve (AUC) of 0.81 in detecting infections. Critically, the model continued to perform at consistently high levels across diverse patient demographics, mitigating concerns over potential bias.

    “Our hope is that the AI models we developed — and the large dataset they were trained on — have the potential to fundamentally reshape how surgical follow-up is delivered,” said Hojjat Salehinejad, Ph.D., a senior associate consultant of health care delivery research within the Kern Center for the Science of Health Care Delivery and co-senior author. “Prospective studies are underway to evaluate how well this tool integrates into day-to-day surgical care.”

    Future applications in clinical workflows

    Although the tool currently serves as a proof of concept, the research team is exploring how it could be used in real-world surgical care workflows.

    “For patients, this could mean faster reassurance or earlier identification of a problem,” said Hala Muaddi, M.D., Ph.D., a hepatopancreatobiliary fellow at Mayo Clinic and first author. “For clinicians, it offers a way to prioritize attention to cases that need it most, especially in rural or resource-limited settings.”

    The team are hopefully that this technology could help support patients who are recovering from surgery at home. With further validation, they believe it could be used as a frontline screening tool to alert physicians to potentially concerning incisions.

    Reference: Hala Muaddi, Choudhary A, Lee F, et al. Imaging Based Surgical Site Infection Detection Using Artificial Intelligence. Ann Surg. 2025. doi: 10.1097/sla.0000000000006826

    This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source. Our press release publishing policy can be accessed here.

    This content includes text that has been generated with the assistance of AI. Technology Networks’ AI policy can be found here.

    Continue Reading

  • Narrow Spaces Trigger Stem Cells To Become Bone Cells

    Narrow Spaces Trigger Stem Cells To Become Bone Cells


    Register for free to listen to this article

    Thank you. Listen to this article using the player above.

    In a discovery that could reshape approaches to regenerative medicine and bone repair, researchers have found that human stem cells can be prompted to begin turning into bone cells simply by squeezing through narrow spaces.

    The study suggests that the physical act of moving through tight, confining spaces, like those between tissues, can influence how stem cells develop. This could open new possibilities for engineering materials and therapies by guiding cell behaviour using physical, rather than chemical, signals.

    The research was led by Assistant Professor Andrew Holle (Biomedical Engineering and the NUS Mechanobiology Institute) and was published on 8 May 2025 in the journal Advanced Science.

    Asst Prof Holle leads the Confinement Mechanobiology Lab at NUS. His lab studies how physical constraints – especially the tight spaces cells encounter as they move – affect how cells behave, function, and develop. While most earlier research in this area focused on cancer and immune cells, his team is among the first to explore how these forces affect stem cells, with the aim of applying their findings to future therapies.

    Mechanical ‘memory’

    The researchers focused on a type of adult stem cell known as a mesenchymal stem cell, or MSC. These cells are found in bone marrow and other tissues and are known for their ability to develop into bone, cartilage, and fat cells. Because of these properties, MSCs are widely used in research on tissue repair and regeneration.

    “To test how physical forces influence stem cell fate, we developed a specialised microchannel system that mimics the narrow tissue spaces cells navigate in the body,” said Asst Prof Holle.

    They found that when MSCs squeezed through the smallest channels (just three micrometres wide), the pressure caused lasting changes to the cells’ shape and structure. These cells showed increased activity in a gene called RUNX2, which plays a key role in bone formation. Even after exiting the channels, they retained this effect – suggesting they carry a kind of mechanical ‘memory’ of the experience.

    “Most people think of stem cell fate as being determined by chemical signals,” Asst Prof Holle said. “What our study shows is that physical confinement alone – squeezing through tight spaces – can also be a powerful trigger for differentiation.”

    While traditional methods of directing stem cells rely on chemical cues or growing them on stiff or soft materials, Asst Prof Holle’s team believes confinement-based selection may offer a simpler, cheaper, and potentially safer alternative. “This method requires no chemicals or genetic modification – just a maze for the cells to crawl through,” he said. “In theory, you could scale it up to collect millions of preconditioned cells for therapeutic use.”

    The researchers say their findings could help improve the design of biomaterials and scaffolds used in bone repair, by creating physical environments that naturally encourage the right kind of cell development. “By tuning the mechanical properties of materials, we might be able to steer stem cells more reliably toward the cell types we want,” Asst Prof Holle said.

    Next steps

    The approach could one day be used to speed up recovery from bone fractures or enhance the effectiveness of stem cell therapies. “We’d like to test whether preconditioned cells that have gone through this mechanical selection are better at promoting healing when introduced at injury sites,” Asst Prof Holle said. “That’s one of the next steps.”

    Beyond bone repair, the research may have broader implications. MSCs are also known to migrate toward tumours, and the research team is interested in whether mechanically preconditioned cells might be better equipped to move through dense tumour tissue – a challenge that has limited the success of many current cell therapies.

    The group is also exploring whether the technique could apply to more potent stem cell types, such as induced pluripotent stem cells (iPSCs), which can develop into almost any tissue in the body.

    “We suspect that confinement plays a role even in embryonic development,” Asst Prof Holle said. “Cells migrating through crowded environments early in life are exposed to mechanical stress that could shape their fate. We think this idea has potential far beyond just MSCs.”

    Reference: Gao X, Li Y, Lee JWN, et al. Confined migration drives stem cell differentiation. Adv Sci. 2025;12(21):2415407. doi: 10.1002/advs.202415407

    This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source. Our press release publishing policy can be accessed here.

    Continue Reading

  • ‘I made a mistake’ – Gabriel Bortoleto explains error that led to early exit from British Grand Prix

    ‘I made a mistake’ – Gabriel Bortoleto explains error that led to early exit from British Grand Prix

    Gabriel Bortoleto has explained how opting to pit for slick tyres at the start of the British Grand Prix led to his early exit from the race, with the Brazilian admitting that he “made a mistake” in the changing conditions.

    While most cars prepared to take the start on intermediate tyres – following intermittent heavy rain showers at Silverstone in the hours prior to the race – a few, including Bortoleto, dived into the pits at the end of the formation lap to bolt on the slicks.

    The Kick Sauber driver returned to the track on the medium compound but spun off just a few laps later, ending up in the gravel before getting going again. With a piece of his front wing left near the track, the yellow flags were thrown and Bortoleto subsequently pulled off, bringing out a Virtual Safety Car.

    Asked to talk through what had happened afterwards, Bortoleto responded: “It’s not difficult, it’s very simple what happened. I made a mistake, I decided to go for the mediums for the slicks set.

    “I thought the track was going to dry up a bit quickly, with a lot of wind we were having this week and sunny conditions at that moment. I thought it was the right call to do at the time, I didn’t expect rain as well after, so I thought, ‘Let’s do this, maybe we can gain some positions here’.

    “Then the restart was very tricky, low grip. I went on the power out of T1 and I had a big snap, tried to correct it and I didn’t make it.

    “I touched the rear wing on the wall and the rear wing was a bit broken, so I preferred to stop on track not to risk any debris staying around, and [it was] just race over for me there.”

    Despite the challenging end to his own race, there was plenty of reason for the team to celebrate after Nico Hulkenberg scored a long-awaited debut F1 podium by finishing the race in P3, a result that Bortoleto was delighted about.

    “It’s such a special day for me, for the team,” the 20-year-old smiled. “I really enjoy working with Nico – for me he’s one of the most talented drivers I’ve ever met in my life.

    “Definitely the best team mate I ever had in many senses, [as a] person, as a driver and everything, and I think he deserves it. He’s such a hard worker and he puts a lot of effort in things. He’s been able this year to just do outstanding races, and he deserves it. Just amazing.”

    The result has hauled Kick Sauber into sixth place of the Teams’ Championship on 41 points, putting them five points clear of Racing Bulls and Aston Martin in seventh and eighth respectively.

    Continue Reading

  • King Charles, Emmanuel Macron’s Windsor meeting: Exclusive details released

    King Charles, Emmanuel Macron’s Windsor meeting: Exclusive details released



    King Charles, Emmanuel Macron’s Windsor meeting: Exclusive details released

    King Charles, Queen Camilla, Prince William and Kate Middleton welcomed French President Emmanuel Macron to Britain on Tuesday for the first state visit by a European leader since Brexit.

    Macron and King Charles, who enjoy a strong personal relationship, were all smiles as they walked together alongside their wives, Brigitte and Queen Camilla.

    The Prince and Princess of Wales were the first to greet the Macrons upon their arrival in England.

    The future king and Queen all traveled to Windsor, where the French President and his wife were formally welcomed by King Charles and Queen Camilla before taking a horse-drawn carriage ride to Windsor Castle for a military display and traditional inspection.

    The royal family’s official Instagram account shared new stunning photos from grand reception, stating: “The King and Queen, and The Prince and Princess of Wales, have welcomed President @EmmanuelMacron and Mrs. Macron to Windsor Castle.”

    King Charles and Emmanuel Macron traveled in the 1902 State Landau carriage during a precession at Windsor Castle. The monarch hosted the first state visit at Windsor Castle in 11 years as Buckingham Palace is all about logistics.

    The 76-year-old monarch is expected to emphasise “the multitude of complex threats” both countries face in a speech he will deliver at a state dinner at Windsor Castle.

    Macron posted on X (formerly Twitter) on his arrival that “there is so much we can build together”.

    The two have countries jointly announced that French nuclear energy utility EDF will invest £1.1 billion ($1.5 billion) in a project to build a nuclear power station in eastern England.

    Continue Reading

  • Brooklyn Nets Acquire Michael Porter Jr. – NBA

    Brooklyn Nets Acquire Michael Porter Jr. – NBA

    1. Brooklyn Nets Acquire Michael Porter Jr.  NBA
    2. Nuggets absolutely fleeced the Nets in the Cam Johnson trade  Nugg Love
    3. Nuggets newcomer Cam Johnson’s path to NBA stardom paved by hard work, smarts: ‘He’s savvy’  Indiana Gazette Online
    4. Ian Begley: Nets announce Michael Porter Jr./Cam Johnson trade that includes DEN’s unprotected 203…  HoopsHype
    5. Did the Nets make a error trading Cam Johnson for Michael Porter Jr.?  Yahoo Sports

    Continue Reading

  • Is Jasprit Bumrah India’s best bowler ever?

    Is Jasprit Bumrah India’s best bowler ever?

    As West Indies pace great Curtly Ambrose put it – while others ran marathons, Bumrah sprinted to greatness in short bursts and sharp spells.

    Ricky Ponting also agrees, “You don’t score off him. Then batting becomes uncomfortable. That’s what the best of the best do.”

    Adam Gilchrist in 2024 said he was lost for words trying to describe Jasprit Bumrah. He declared the Indian superstar might be the greatest fast bowler ever witnessed on Australian soil.

    “It is just a different ball game, a different planet, that Bumrah is playing on compared to everyone else in the game. It is so impressive to watch,” Gilchrist told Fox Cricket. “We are running out of words to describe it. He is one of the best we have ever seen.”

    At 31, Jasprit Bumrah’s best years may still be ahead of him. Others might have more on the wickets column, but very few, if any, bowlers in world cricket can match his blend of economy, strike rate, multi-format mastery and unmatched brilliance in clutch moments.

    Perhaps the only thing casting any doubt over Bumrah retiring with truly elite numbers across formats is his patchy injury record.

    Bumrah’s Injury concerns

    Bumrah’s unorthodox slingshot action, while a key weapon for him, has also taken a toll on his body, particularly his lower back.

    New Zealand’s Shane Bond, one of the fastest bowlers of all time and the coach of Jasprit Bumrah at the Mumbai Indians for several years, feels Bumrah’s unique action isn’t biomechanically inefficient per se.

    His short run-up, sudden acceleration towards the end, strong locked front knee and long arms coupled with a timely snap in his wrist help him generate deceptive pace and swing.

    However, the action also puts stress on his knees and lower back, which can gradually build up to cause more serious issues like stress fractures.

    “The force will go up the chain: through the calf, the hamstring, the glutes and the back. And so if you are not strong in those areas, the force will end up in the back at some point,” Bond explained during an interview with ESPNCricinfo.

    “So if you think of any top bowler, at some point in time when you have been bowling for a long time, your hamstrings, your calves, are going to fatigue and that force will get taken somewhere,” the Kiwi ace added.

    Over the course of his career, Bumrah has suffered multiple lower back injuries, including stress fractures. One of these kept him out of action for 11 months and required him to undergo surgery.

    The solution, according to Bond, is not changing his action but to optimally manage Bumrah’s workload, especially while transitioning between T20 cricket to Tests.

    “First time he (Bumrah) had a stress fracture (2019), he came out of IPL and played Test cricket. So you are bowling 20 overs a week and all of a sudden you bowl 50 overs a week,” Bond noted.

    Meanwhile, Bumrah, for his part, has never let an injury keep him down and has always managed to bounce back in style.

    “People had said in all these years (I will play only) eight months, some said 10 months but now I have played 10 years of international cricket, 12-13 years of IPL,” Bumrah remarked in 2025.

    “Even now people say (after every injury), he will be finished, he is gone. Let them say, I will do my own work. Every four months these things will crop up, but as long as almighty wants, I will play.”

    With cricket returning to the Olympics, Bumrah recently expressed his desire to manage his workload and stay fit to represent India at the LA 2028 Games, which will feature the T20 format of the sport.


    Continue Reading

  • Ryan Reynolds, Rob Mac, Roy Wood Jr. Set for Just For Laughs 2025

    Ryan Reynolds, Rob Mac, Roy Wood Jr. Set for Just For Laughs 2025

    Ryan Reynolds and Rob Mac (formerly McElhenney), executive producers of Welcome to Wrexham, are bringing their creative partnership to Montreal for the Just For Laughs comedy festival.

    Mac, who recently legally changed his name, will receive the Generation Award during prize-giving at the upcoming Montreal comedy festival’s industry event set to run July 23 to 25. Reynolds, who along with Mac is a co-owner of the Wrexham AFC football (soccer for Americans) club that inspired the  FX docuseries Welcome to Wrexham and its spinoff series, Necaxa, will bring his own comic edge when presenting the award to Mac.

    Other prize winners unveiled on Tuesday include Roy Wood Jr. presenting a lifetime achievement award to Amazon’s Clean Slate comedy co-star George Wallace; and Benito Skinner, known for his online persona Benny Drama and as the creator and star of the Prime Video comedy Overcompensating, will receive a breakout comedy star of the year prize from Mary Beth Barone.

    The rising comedy star of the year award will go to Hannah Berner, the reality star turned podcaster and stand-up comedian. The Just For Laughs Award Show will be part of the ComedyPRO 2025 industry programming in Montreal.

    The returning New Faces of Comedy program, to showcase undiscovered new comic talent, will be hosted by Ian Hecox and Anthony Padilla of SMOSH. Just For Laughs is launching this year a New Faces Writers program in partnership with Rob Mac’s More Better Productions.

    Also set for Montreal is the Just For Laughs comedy shorts and pilots showcase and competition presented in partnership with Will Arnett’s Electric Avenue banner. Just For Laughs, a once-dominant stand-up comedy showcase for Hollywood, is returning this year under new owner ComediHa! after a post-bankruptcy restructuring.

    The Montreal-based festival group got its start in the 1980s as an annual gathering where Hollywood discovered the next big thing for sitcoms and movie roles. But the rise of the internet and social media as discovery platforms for self-promoting comedians has pushed the Canadian festival down the assembly line for nascent comedy talent.

    Despite that disruption, Los Angeles and New York talent scouts will be thick on the ground in Montreal later this month for keynote addresses and panels, including ones for adapting comedy for the world market and casting comedy talent in a shifting entertainment landscape.

    The 11-day Just For Laughs festival, including indoor and outdoor comedy showcases, is set to run in Montreal  from July 16 to 27.

    Continue Reading

  • Suunto Brings Unbeatable Prime Day Discounts to Fuel Your Summer Adventures

    Suunto Brings Unbeatable Prime Day Discounts to Fuel Your Summer Adventures

    SEATTLE, July 8, 2025 /PRNewswire/ — Suunto, a leading innovator in sports wearables, is offering exclusive Prime Day deals on its best-selling watches and headphones. From July 8 to 11, Prime members can unlock limited-time savings and gear up with trusted equipment for every adventure.

    Featured Prime Day Offers

    Suunto 9 Peak Pro – 20% OFF
    The powerful multisport watch with extended battery life and military-grade durability.

    • Sapphire touchscreen and stainless steel bezel
    • Powerful processor and redesigned user interface
    • 4 satellite systems for best positioning accuracy
    • 40 hours of battery life in the best GPS mode
    • Advanced training metrics with 100+ sport modes

    Suunto Race S – 20% OFF
    The ultimate performance watch for racing and training. Just smaller.

    • High-definition AMOLED screen
    • Free offline maps
    • Advanced training metrics with 100+ sport modes
    • HRV recovery measurement
    • Designed in Finland

    Suunto Vertical Titanium Solar – 16% OFF
    The large screen adventure watch for outdoor expeditions with solar charging.

    • Sapphire touchscreen
    • Dual-band GPS/GNSS for greater accuracy
    • Extended battery life for up to 60 days of daily use
    • Solar charging capability increases battery life by 30% on sunny days.
    • Advanced training metrics with 100+ sport modes

    Suunto Sonic – 39% OFF
    Bone conduction headphones with excellent sound quality

    • 31g lightweight open-ear design
    • Rich sound experience and Enhanced bass
    • Dual microphone and cVc noise reduction
    • Charging time of 1 hour for up to 10 hours of music play time
    • IP55 sweatproof & water resistant

    Don’t miss your chance to unlock extraordinary savings on Suunto’s complete range of GPS watches, headphones, dive computers, and adventure accessories. Visit Suunto’s Amazon Store during Prime Day for these top picks—and discover even more Prime Day deals that fuel your next expedition.

    About Suunto 

    In 1936, our founder, Finnish inventor Tuomas Vohlonen, pioneered a new standard for precision in navigation with his field compass, which was stronger, steadier, and more accurate than any other handheld navigational tool in existence. It was the first of many products built to withstand the harsh conditions of Finland. 

    In the near century since then, Tuomas’s spirit of innovation has continued to chart Suunto’s course. From some of history’s first dive computers and high-altitude wrist altimeters to the GPS watches of modern day, Suunto continues to be a trusted companion for outdoor adventurers across the globe. It remains our primary mission to support explorers, athletes, and weekend warriors alike, giving them the tools to dive deeper, climb higher, and push the limits of human potential. To learn more about Suunto, please visit www.suunto.com

    SOURCE Suunto

    Continue Reading

  • Real-World Study Shows Differences in Efficacy Among CDK4/6 Inhibitors for Advanced Breast Cancer

    Real-World Study Shows Differences in Efficacy Among CDK4/6 Inhibitors for Advanced Breast Cancer

    Medical illustration of breast cancer

    In patients with endocrine-sensitive HR-positive/HER2-negative advanced breast cancer, the cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) abemaciclib (Verzenio), palbociclib (Ibrance), and ribociclib (Kisqali) demonstrated varying real-world progression-free survival (rwPFS) outcomes, according to findings from the multicenter PALMARES-2 trial (NCT06805812) published in Annals of Oncology.1

    After a median follow-up of 34.1 months, abemaciclib and ribociclib were associated with significantly longer rwPFS compared with palbociclib. The adjusted hazard ratio (aHR) for abemaciclib versus palbociclib was 0.76 (95% CI, 0.63-0.92; P =.004), whereas ribociclib vs palbociclib showed an aHR of 0.83 (95% CI, 0.73-0.95; P =.007). No significant difference was observed between abemaciclib and ribociclib (aHR, 0.91; 95% CI, 0.73-1.14; P =.425).

    In patients with endocrine-sensitive disease, only abemaciclib was associated with better rwPFS when compared with palbociclib (aHR, 0.75; 95% CI, 0.64-0.87; P <.001). In patients who were premenopausal or had endocrine-resistant or luminal B-like disease, abemaciclib and ribociclib were more effective than palbociclib (aHR 0.77; 95% CI, 0.63-0.93, P =.008; ribociclib vs palbociclib: aHR 0.75; 95% CI, 0.58-0.98; P =.034), according to investigators. Abemaciclib was more effective than ribociclib and palbociclib in patients with de novo metastatic disease, and more effective than palbociclib in patients with poorer ECOG performance status. All 3 CDK4/6is were similarly effective in patients who had bone-only disease.

    Study Details

    A total of 1982 patients were enrolled across 18 Italian cancer centers, in which they received either palbociclib (n = 789), ribociclib (n = 736), or abemaciclib (n = 457), determined by physician choice, in the first-line treatment of HR-positive, HER2-negative advanced breast cancer. Data were collected from electronic health records in each participating center.

    Overall, the median age was 63 years (range, 53-72) and of the 1982 patients, 33% had endocrine-resistant tumors, 18% were premenopausal, and 30% had de novo metastatic disease. Abemaciclib-treated patients were more likely to have endocrine-resistant disease, liver metastases and lower progesterone receptor tumor expression, while patients receiving ribociclib were younger and more likely to be premenopausal; finally, palbociclib was more commonly prescribed to patients with a poorer ECOG performance status.

    The primary end point was rwPFS, defined as the time interval between the initiation of estrogen therapy (ET) plus CDK4/6is and the detection of disease progression, as evaluated according to radiological (CT/PET scans), clinical (clinical tumor measurements and evolution of patient status), or biochemical criteria (CA15.3 measurements), or patient death, whichever occurred first.

    Secondary end points compared the rwPFS associated with the 3 CDK4/6is in clinically relevant patient cohorts, such as premenopausal patients, older patients (age >75 years at the time of CDK4/6i initiation) or patients with liver metastases, bone-only disease, luminal B-like tumors, de novo metastatic disease, or poor ECOG performance status (≥ 1).

    Exploratory end points were also explored and included time to next treatment or death, time to chemotherapy or death, and overall survival.

    Treatment Discontinuation

    Any dose reduction occurred with similar frequency in patients receiving palbociclib (n = 395, 50.9%), ribociclib (n = 349, 48.7%) and abemaciclib (n = 233, 52.4%), and permanent CDK4/6i discontinuation rates for any reason were 484 (61.5%), 290 (39.4%) and 183 (40.0%), respectively. Discontinuation was attributed to disease progression (n = 864, 43.6%), hematological, gastrointestinal and/or liver toxicities (n = 50, 2.5%), or other toxicities/reasons (n = 43, 2.2%).

    According to Provenzano et al, “these results…are unique in the field with published works comparing the 3 CDK 4/6is in the real-world setting mostly consist[ing] of relatively small case series lacking sufficient power for effectiveness comparisons…” The investigators also noted a number of limitations with the study, including its retrospective and observational nature and that the prescription of one or another CDK 4/6i may have been influenced by the time of approval and registration of the individual agents.

    REFERENCE:
    Provenzano L, Dieci MV, Curigliano G, et al. Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR-positive/HER2-negative BC patients: results from the multicenter PALMARES-2 study. Ann Oncol. 2025;36(7):762-774. doi:10.1016/j.annonc.2025.03.023

    Continue Reading

  • PM Shehbaz pushes local resources for Pakistan’s economic self-reliance – ARY News

    1. PM Shehbaz pushes local resources for Pakistan’s economic self-reliance  ARY News
    2. Business leaders praise PM Shehbaz’s economic leadership  Ptv.com.pk
    3. A delegation of renowned businessmen meet with Prime Minister Muhammad Shehbaz Sharif  Associated Press of Pakistan
    4. PM Shehbaz vows inclusive economic growth through private sector dialogue  nation.com.pk

    Continue Reading